Stockreport

Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) [Yahoo! Finance]

Biophytis SA - American Depositary Share  (BPTS) 
PDF PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris: ALBPS), ("Biophytis" or the "Company"), a clinical-stag [Read more]